PMC:7205724 / 771-989
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
56 | 13-21 | Species | denotes | patients | Tax:9606 |
57 | 79-88 | Species | denotes | SARS-CoV2 | Tax:2697049 |
58 | 120-128 | Species | denotes | patients | Tax:9606 |
68 | 37-45 | Disease | denotes | COVID-19 | MESH:C000657245 |
69 | 141-149 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T2 | 1-7 | Body_part | denotes | Plasma | http://purl.org/sig/ont/fma/fma62970 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T9 | 37-45 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T10 | 79-83 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T11 | 141-149 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T3 | 1-7 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | Plasma |
T4 | 89-92 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T6 | 194-209 | Chemical | denotes | corticosteroids | http://purl.obolibrary.org/obo/CHEBI_50858 |
LitCovid-sample-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T5 | 194-209 | Chemical | denotes | corticosteroids | http://purl.obolibrary.org/obo/CHEBI_50858 |
LitCovid-sample-PD-NCBITaxon
Id | Subject | Object | Predicate | Lexical cue | ncbi_taxonomy_id |
---|---|---|---|---|---|
T10 | 37-45 | Species | denotes | COVID-19 | NCBItxid:2697049 |
T11 | 79-88 | Species | denotes | SARS-CoV2 | NCBItxid:2697049 |
T12 | 141-149 | Species | denotes | COVID-19 | NCBItxid:2697049 |
LitCovid-sample-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T13 | 1-150 | Sentence | denotes | Plasma from patients recovered from COVID-19 that contains antibodies against SARS-CoV2 has shown promising results in patients with severe COVID-19. |
LitCovid-sample-Pubtator
Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
---|---|---|---|---|---|
56 | 13-21 | Species | denotes | patients | Tax:9606 |
68 | 37-45 | Disease | denotes | COVID-19 | MESH:C000657245 |
57 | 79-88 | Species | denotes | SARS-CoV2 | Tax:2697049 |
58 | 120-128 | Species | denotes | patients | Tax:9606 |
69 | 141-149 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sample-Enju
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T121 | 1-7 | NN | denotes | Plasma |
T122 | 8-12 | IN | denotes | from |
T123 | 13-21 | NNS | denotes | patients |
T124 | 22-31 | VBN | denotes | recovered |
T125 | 32-36 | IN | denotes | from |
T126 | 37-45 | NN | denotes | COVID-19 |
T127 | 46-50 | WDT | denotes | that |
T128 | 51-59 | VBZ | denotes | contains |
T129 | 60-70 | NNS | denotes | antibodies |
T130 | 71-78 | IN | denotes | against |
T131 | 79-88 | NN | denotes | SARS-CoV2 |
T132 | 89-92 | VBZ | denotes | has |
T133 | 93-98 | VBN | denotes | shown |
T134 | 99-108 | JJ | denotes | promising |
T135 | 109-116 | NNS | denotes | results |
T136 | 117-119 | IN | denotes | in |
T137 | 120-128 | NNS | denotes | patients |
T138 | 129-133 | IN | denotes | with |
T139 | 134-140 | JJ | denotes | severe |
T140 | 141-149 | NN | denotes | COVID-19 |
T141 | 151-155 | RB | denotes | Also |
T142 | 155-156 | -COMMA- | denotes | , |
T143 | 157-161 | NNP | denotes | IVIG |
T144 | 161-162 | -COMMA- | denotes | , |
T145 | 163-171 | VBN | denotes | combined |
T146 | 172-176 | IN | denotes | with |
T147 | 177-190 | NN | denotes | moderate-dose |
T148 | 191-193 | IN | denotes | of |
T149 | 194-209 | NNS | denotes | corticosteroids |
T150 | 209-210 | -COMMA- | denotes | , |
T151 | 211-216 | MD | denotes | might |
R114 | T121 | T122 | arg1Of | Plasma,from |
R115 | T123 | T122 | arg2Of | patients,from |
R116 | T123 | T124 | arg2Of | patients,recovered |
R117 | T124 | T125 | arg1Of | recovered,from |
R118 | T126 | T125 | arg2Of | COVID-19,from |
R119 | T126 | T127 | arg1Of | COVID-19,that |
R120 | T126 | T128 | arg1Of | COVID-19,contains |
R121 | T129 | T128 | arg2Of | antibodies,contains |
R122 | T129 | T130 | arg1Of | antibodies,against |
R123 | T131 | T130 | arg2Of | SARS-CoV2,against |
R124 | T121 | T132 | arg1Of | Plasma,has |
R125 | T133 | T132 | arg2Of | shown,has |
R126 | T121 | T133 | arg1Of | Plasma,shown |
R127 | T135 | T133 | arg2Of | results,shown |
R128 | T135 | T134 | arg1Of | results,promising |
R129 | T133 | T136 | arg1Of | shown,in |
R130 | T137 | T136 | arg2Of | patients,in |
R131 | T137 | T138 | arg1Of | patients,with |
R132 | T140 | T138 | arg2Of | COVID-19,with |
R133 | T140 | T139 | arg1Of | COVID-19,severe |
R136 | T143 | T144 | arg1Of | IVIG,"," |
R137 | T143 | T145 | arg2Of | IVIG,combined |
R138 | T145 | T146 | arg1Of | combined,with |
R139 | T147 | T146 | arg2Of | moderate-dose,with |
R140 | T147 | T148 | arg1Of | moderate-dose,of |
R141 | T149 | T148 | arg2Of | corticosteroids,of |
R143 | T143 | T151 | arg1Of | IVIG,might |
LitCovid-sample-PD-FMA
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T2 | 1-7 | Body_part | denotes | Plasma | http://purl.org/sig/ont/fma/fma62970 |
LitCovid-sample-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T9 | 37-45 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T10 | 79-88 | Disease | denotes | SARS-CoV2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T11 | 141-149 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T13 | 1-150 | Sentence | denotes | Plasma from patients recovered from COVID-19 that contains antibodies against SARS-CoV2 has shown promising results in patients with severe COVID-19. |